UROV Market Cap History

Below is a table of the UROV market cap history going back to 9/27/2018:

Date UROV Market Cap

Also see: UROV Shares Outstanding History
and UROV YTD Return
UROV Historical Market Cap:
+19.04% CAGR
UROV Historical Market Cap: +19.04% CAGR

Mouse over chart for data details
9/27/2018 ...2/11/2021
Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for urologic conditions. Co.'s primary product candidate, vibegron is an oral, once-daily, small molecule that was observed to be selective for the human beta-3 adrenergic receptor in in vitro assays. Vibegron is being developed for various potential indications: overactive bladder (OAB), the treatment of OAB in men with benign prostatic hyperplasia, and the treatment of abdominal pain due to irritable bowel syndrome. In addition, Co.'s second product candidate, URO-902 is a gene therapy that it is developing for patients with OAB who have failed oral pharmacological therapy. We show 12 historical shares outstanding datapoints in our UROV shares outstanding history coverage, used to compute UROV market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing UROV market cap history over the course of time is important for investors interested in comparing UROV's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of UROV versus a peer is one thing; comparing UROV market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like UROV can fluctuate over the course of history. With this page we aim to empower investors researching UROV by allowing them to research the UROV market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree UROV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Urovant Sciences (UROV) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

UROY Market Cap History
URTH Market Cap History
USCT Market Cap History
USEA Market Cap History
USMF Market Cap History
USXF Market Cap History
UTAA Market Cap History
UTME Market Cap History
UTSL Market Cap History
UWM Market Cap History
More Miscellaneous companies »


UROV Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.